(Q40464008)

20 September 2017

Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives. (English)

1 reference

20 September 2017

1

1 reference

20 September 2017

Xiong Yuan

2

1 reference

20 September 2017

Donglei Yu

series ordinal

3

1 reference

20 September 2017

K H Lee

series ordinal

4

1 reference

20 September 2017

Chin Ho Chen

series ordinal

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

332

1 reference

20 September 2017

2

1 reference

20 September 2017

623-628

1 reference

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

20 September 2017

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

inferred from DOI database lookup

7 January 2021

based on heuristic

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Complete nucleotide sequences of functional clones of the AIDS virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Anti-AIDS agents. 37. Synthesis and structure-activity relationships of (3'R,4'R)-(+)-cis-khellactone derivatives as novel potent anti-HIV agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Anti-HIV Agents. Part 55: 3′R,4′R-Di-(O)-(−)-camphanoyl-2′,2′-dimethyldihydropyrano[2,3-f]chromone (DCP), a Novel Anti-HIV agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Anti-AIDS agents. 60. Substituted 3'R,4'R-di-O-(-)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP) analogues as potent anti-HIV agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

The role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.033

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2004.11.033

1 reference

20 September 2017

1 reference